NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

495.59 +6.35 (+1.30%)
As of 1:11 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jonathan J. Mazelsky President, CEO & Director 2.77M 11.81M 1961
Mr. Brian P. McKeon CFO, Executive VP & Treasurer 1.4M 173.73k 1962
Mr. Michael J. Lane Executive VP and GM of Reference Laboratories & Information Technology 1.17M 5.67M 1969

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300 https://www.idexx.com
Sector: 
Healthcare
Full Time Employees: 
11,000

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Corporate Governance

IDEXX Laboratories, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 9; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 01, 2024
IDEXX Laboratories, Inc. Earnings Call

Related Tickers

MTD Mettler-Toledo International Inc.
1,243.84
+0.89%
 
MEDP Medpace Holdings, Inc.
395.08
+1.36%
 
WAT Waters Corporation
310.12
+0.57%
 
DHR Danaher Corporation
247.92
+0.86%
 
IQV IQVIA Holdings Inc.
235.71
+0.74%
 
TMO Thermo Fisher Scientific Inc.
573.78
+0.36%
 
ICLR ICON Public Limited Company
309.71
+3.21%
 
CRL Charles River Laboratories International, Inc.
229.01
+0.53%
 
A Agilent Technologies, Inc.
138.22
+1.36%
 
ILMN Illumina, Inc.
123.64
+2.14%